BioPlete™ Advanced Formula for Chronic Pain

N/A

Waitlist Available

Led By Pamela Kane

Research Sponsored by Ethos Research & Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 21 and 42

Summary

This trial is testing a new pain measurement test and a nutritional supplement in adults with chronic pain. The test identifies markers related to pain, and the supplement aims to improve pain by addressing nutritional issues.

Eligible Conditions

Chronic Pain

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 21 and 42

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 21 and 42

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 21 and 42 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change from baseline (Day 0) in 36-Item Short Form Survey (SF-36) questionnaire scores (0-100; higher is better), assessed on Day 42.

Secondary study objectives

Change from baseline (Day 0) in 36-Item Short Form Survey (SF-36) questionnaire scores (0-100; higher is better), assessed on Day 21.

Change from baseline (Day 0) in Foundation Pain Index (FPI) (0-100; higher is worse), assessed on Days 21 and 42.

Change from baseline (Day 0) in Numeric Rating Scale (NRS) scores for pain (0-10, higher is worse), assessed on Days 21 and 42.

Other study objectives

Change from baseline (Day 0) in Morphine Milligrams Equivalent (MME), assessed on Days 21 and 42.

Within the confines of this study design, duration and population, to determine change from baseline (Day 0) the relative safety of the Test Product over 1.5 months of use.